It's no secret that Ozempic isn't going anywhere, but the weight loss drug category does seem to be rapidly evolving.

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

People with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of hospital readmission, wound re-opening and hematoma after surgery ...

As the weight-loss drugs become more popular, consumer habits are starting to reflect changing consumption behavior, ...

For this review, the authors searched for randomized controlled trials published in MEDLINE, Embase, and Cochrane CENTRAL ...

A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...

McKinsey & Company’s 2024 Future of Wellness study – which surveyed more than 5,000 consumers across the United States, ...

Researchers have found that polyphenols cause the secretion of hormones that may help lower a risk of developing type 2 ...

A plant-based diet invention high in fibre may slow the spread of multiple myeloma, a rare, incurable blood cancer, in at-risk individuals.

On the surface, the formula for weight loss seems simple: eat less and move more. But giving that advice to someone with ...

So, this year, forget those fad diets—or worse, crash diets—that undermine your health. Instead, consider using WeightWatchers, which claimed the spot for the number one best diet for weight loss.

These drugs, called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), work in several different ways to help people lose ...